261 related articles for article (PubMed ID: 3876465)
21. Immunotherapy of cancer using interleukin 2: current status and future prospects.
Rosenberg SA
Immunol Today; 1988 Feb; 9(2):58-62. PubMed ID: 3076761
[No Abstract] [Full Text] [Related]
22. [Interleukin 2].
Taguchi T; Kimoto Y
Gan To Kagaku Ryoho; 1987 May; 14(5 Pt 1):1203-7. PubMed ID: 3495239
[TBL] [Abstract][Full Text] [Related]
23. The adoptive immunotherapy of cancer using the transfer of activated lymphoid cells and interleukin-2.
Rosenberg SA
Semin Oncol; 1986 Jun; 13(2):200-6. PubMed ID: 3520827
[No Abstract] [Full Text] [Related]
24. [Adoptive immunotherapy using interleukin-2 and interleukin-2-activated lymphocytes].
van de Loosdrecht AA; Ossenkoppele GJ; Beelen RH
Ned Tijdschr Geneeskd; 1989 Oct; 133(40):1994-5. PubMed ID: 2812087
[No Abstract] [Full Text] [Related]
25. Antitumor properties of mononuclear cells activated by combined treatment with oxidizing mitogens and interleukin-2: basic and clinical studies.
Novogrodsky A; Stenzel KH
Bull N Y Acad Med; 1989 Jan; 65(1):120-7. PubMed ID: 2605394
[No Abstract] [Full Text] [Related]
26. [A new approach to immunotherapy of cancer based on autologous T-lymphocytes].
Dosne Pasqualini C; Laguens RP
Medicina (B Aires); 1987; 47(3):307-12. PubMed ID: 3326997
[No Abstract] [Full Text] [Related]
27. Interleukin-2 and killer T cells.
Sticklin LA
Am J Nurs; 1987 Apr; 87(4):468-9. PubMed ID: 3494403
[No Abstract] [Full Text] [Related]
28. Possible application of natural killer cells and interleukin-2 in therapy of human leukemia.
Lotzová E
Prog Clin Biol Res; 1987; 244():259-66. PubMed ID: 3498951
[No Abstract] [Full Text] [Related]
29. Antitumor efficacy of recombinant interleukin 2-activated killer cells against endometrial cancers.
Inoue M; Shimizu H; Shimizu C; Sasagawa T; Ueda G; Tanizawa O; Nishida M; Ishiwata I
Nihon Sanka Fujinka Gakkai Zasshi; 1987 Jan; 39(1):143-4. PubMed ID: 3493309
[No Abstract] [Full Text] [Related]
30. Adoptive immunotherapy in gastrointestine malignancies using interleukin-2. Current results and future prospects.
Marshall GD
Acta Chir Scand Suppl; 1989; 549():71-4. PubMed ID: 2784605
[No Abstract] [Full Text] [Related]
31. Natural killer cells.
Herberman RB
Prog Clin Biol Res; 1989; 288():161-7. PubMed ID: 2470107
[No Abstract] [Full Text] [Related]
32. Immunotherapy of patients with advanced cancer using interleukin-2 alone or in combination with lymphokine activated killer cells.
Rosenberg SA
Important Adv Oncol; 1988; ():217-57. PubMed ID: 3042605
[No Abstract] [Full Text] [Related]
33. [Interleukin 2, killer cells and cancer].
Timonen T
Duodecim; 1988; 104(9):685-9. PubMed ID: 3049038
[No Abstract] [Full Text] [Related]
34. [Using LAK cells in the adoptive immunotherapy in cancers].
Urushizaki I
Rinsho Ketsueki; 1987 Oct; 28(10):1897-8. PubMed ID: 3502569
[No Abstract] [Full Text] [Related]
35. Biological response modifiers in renal cancer.
Ackermann R
Prog Clin Biol Res; 1988; 269():313-28. PubMed ID: 2455907
[No Abstract] [Full Text] [Related]
36. Role of natural killer cells in defense against leukemia: therapeutic considerations.
Lotzová E
Nat Immun Cell Growth Regul; 1988; 7(3):170-9. PubMed ID: 3262822
[No Abstract] [Full Text] [Related]
37. Adoptive immunotherapy of cancer with activated lymphocytes and interleukin-2.
Kradin RL; Kurnick JT
Pathol Immunopathol Res; 1986; 5(3-5):193-202. PubMed ID: 3299346
[No Abstract] [Full Text] [Related]
38. NIH conference. New approaches to the immunotherapy of cancer using interleukin-2.
Rosenberg SA; Lotze MT; Mulé JJ
Ann Intern Med; 1988 Jun; 108(6):853-64. PubMed ID: 3285747
[TBL] [Abstract][Full Text] [Related]
39. [Interleukin-2 and cancer immunotherapy].
Ogarkov VI; Dobkin AI; Ryzhova EV; Okulov VB; Kiselev OI
Vopr Onkol; 1989; 35(2):141-50. PubMed ID: 2648678
[No Abstract] [Full Text] [Related]
40. Interleukin-2 activated cytotoxic lymphocytes and their application in the intraoperative immunotherapy of local tumors.
Grimm EA
Prog Clin Biol Res; 1987; 244():185-95. PubMed ID: 3498948
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
